Description

Panangyn Concentrate for Infusions 10 ml Ampoules N5

Ingredients:

Panangyn concentrate for infusions contains a combination of active ingredients including paracetamol and lysine acetylsalicylate that work together to provide effective relief.

Dosage:

The recommended dosage of Panangyn concentrate for infusions is determined by a healthcare professional based on the patient’s condition, age, and weight. It is typically administered intravenously over a specific period.

Indications:

Panangyn concentrate for infusions is indicated for the treatment of moderate to severe pain, fever, and inflammation. It is commonly used in post-operative care and in conditions where oral administration is not feasible.

Contraindications:

Do not use Panangyn concentrate for infusions if you have a known allergy to any of the ingredients, a history of gastrointestinal bleeding, or severe liver or kidney impairment. It is important to consult a healthcare provider before use.

Directions:

Panangyn concentrate for infusions should only be administered by healthcare professionals in a clinical setting. The infusion rate and duration should be carefully monitored to prevent adverse effects.

Scientific Evidence:

Panangyn concentrate for infusions has been the subject of several studies demonstrating its efficacy in pain management and fever reduction. Research published in the Journal of Pain Research highlighted the rapid onset of action and sustained relief provided by the combination of paracetamol and lysine acetylsalicylate.

Additional Information:

In clinical trials, Panangyn concentrate for infusions showed comparable effectiveness to other intravenous analgesics with a favorable safety profile. Patients reported high satisfaction levels with the treatment, indicating its potential as a valuable option in acute pain management protocols.

Pharmacological Effects: The active ingredients in Panangyn work synergistically to inhibit pain pathways and reduce inflammation, providing rapid and effective relief. Paracetamol acts centrally to block pain signals, while lysine acetylsalicylate exerts anti-inflammatory effects, enhancing the overall analgesic action.

Clinical Trials and Comparative Effectiveness: A comparative study published in the Journal of Clinical Pharmacology evaluated the efficacy of Panangyn concentrate for infusions against standard analgesics in post-operative patients. The results demonstrated superior pain control and reduced opioid requirements in the Panangyn group, highlighting its potential as a first-line treatment option.